COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment
K El Karoui, AS De Vriese - Kidney International, 2022 - Elsevier
The COVID-19 pandemic has profound adverse effects on the population on dialysis.
Patients requiring dialysis are at an increased risk of SARS-CoV-2 infection and mortality …
Patients requiring dialysis are at an increased risk of SARS-CoV-2 infection and mortality …
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study
Abstract Coronavirus disease 2019 (COVID-19) antiviral response in a pan-tumor immune
monitoring (CAPTURE)(NCT03226886) is a prospective cohort study of COVID-19 immunity …
monitoring (CAPTURE)(NCT03226886) is a prospective cohort study of COVID-19 immunity …
Perspective on COVID-19 vaccination in patients with immune-mediated kidney diseases: consensus statements from the ERA-IWG and EUVAS
KI Stevens, E Frangou, JI Shin… - Nephrology Dialysis …, 2022 - academic.oup.com
Patients with immune-mediated kidney diseases are at increased risk of severe coronavirus
disease 2019 (COVID-19). The international rollout of COVID-19 vaccines has provided …
disease 2019 (COVID-19). The international rollout of COVID-19 vaccines has provided …
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort study
KS Hensley, MJ Jongkees, D Geers… - PLoS …, 2022 - journals.plos.org
Background Vaccines can be less immunogenic in people living with HIV (PLWH), but for
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …
SARS-CoV-2 vaccinations this is unknown. In this study we set out to investigate, for the …
Three-dose vaccination elicits neutralising antibodies against omicron
Omicron, the SARS-CoV-2 B. 1.1. 529 variant of concern (VOC), was first detected in
southern Africa in November, 2021, and its BA. 1 sublineage is now dominant in the UK …
southern Africa in November, 2021, and its BA. 1 sublineage is now dominant in the UK …
Severity of COVID-19 after vaccination among hemodialysis patients: an observational cohort study
Results SARS-CoV-2 infection was identified in 1323 patients of different ethnicities
(Asian/other, 30%; Black, 38%; and White, 32%), including 1047 (79%) unvaccinated, 86 …
(Asian/other, 30%; Black, 38%; and White, 32%), including 1047 (79%) unvaccinated, 86 …
Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients
The main limitation of our study is its observational nature, risking unbalanced groups for
comparisons. For example, the AZD–AZD–BNT and BNT–BNT–BNT cohorts are matched …
comparisons. For example, the AZD–AZD–BNT and BNT–BNT–BNT cohorts are matched …
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immune responses and
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive …
infection outcomes were evaluated in 2,686 patients with varying immune-suppressive …
Evaluating the antibody response to SARS-COV-2 vaccination amongst kidney transplant recipients at a single nephrology centre
CA Chukwu, K Mahmood, S Elmakki, J Gorton… - PLoS …, 2022 - journals.plos.org
Background and objectives Kidney transplant recipients are highly vulnerable to the serious
complications of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infections …
complications of severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infections …
Impact of immunosuppressive treatment and type of SARS-CoV-2 vaccine on antibody levels after three vaccinations in patients with chronic kidney disease or kidney …
P Bouwmans, AL Messchendorp, C Imhof… - Clinical kidney …, 2023 - academic.oup.com
Background Patients with chronic kidney disease (CKD) or kidney replacement therapy
demonstrate lower antibody levels after severe acute respiratory syndrome coronavirus 2 …
demonstrate lower antibody levels after severe acute respiratory syndrome coronavirus 2 …